08/26/2025
5:01 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2025
3:25 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2025
3:29 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2025
6:16 PM | Atlas Venture Fund X, L.P. (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SCHEDULE 13D/A | |
08/15/2025
6:23 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
3:16 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2025
12:11 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
08/13/2025
3:24 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2025
3:26 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2025
9:34 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
08/07/2025
9:16 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for GMTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/07/2025
7:37 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2025
7:40 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/25/2025
4:22 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
3:25 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2025
3:27 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2025
3:51 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
3:31 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2025
3:33 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2025
3:20 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Franchi Jean M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2025
4:50 PM | AHMED NADIM (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/16/2025
4:56 PM | AHMED NADIM (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
8:36 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
7:37 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2025
3:48 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
3:34 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Franchi Jean M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2025
7:19 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
12:30 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Quisel John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
3:50 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
4:18 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:22 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Franchi Jean M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025
4:29 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Ratcliffe Liam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:32 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:05 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
4:10 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:14 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:18 PM | Chin Mark (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:23 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
GEMAYEL GEORGES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:25 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Nicholson Donald William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:49 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:25 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Savage William Jacob (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
BREAKING: The House just passed 3 pro-crypto bills! (Ad) THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.  Discover the under-the-radar project I believe will skyrocket as a result. |
05/22/2025
5:31 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
3:40 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G | |
05/07/2025
7:37 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
7:05 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:53 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:22 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Savage William Jacob (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2025
3:44 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form DEF 14A | |
04/24/2025
3:47 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form DEFA14A | |
04/08/2025
7:22 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:00 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:08 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
7:00 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
7:03 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
8:34 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
8:36 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:57 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
03/10/2025
5:46 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:44 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:45 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
7:56 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
7:17 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
7:11 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
6:27 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:29 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:31 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Yu Jonathan Yen-Wen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:33 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:36 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:38 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
6:50 AM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
5:43 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:48 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:33 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:35 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:38 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:40 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Yu Jonathan Yen-Wen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:08 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
02/10/2025
9:25 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
3:28 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
4:24 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 424B5 | |
01/21/2025
4:24 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 424B5 | |
01/21/2025
6:52 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:04 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
4:56 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
6:13 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:20 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Khara Rahul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
3:11 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Quisel John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
4:18 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:21 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Quisel John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
6:41 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon’s BIGGEST warning yet? (Ad) Tesla's About to Prove Everyone Wrong... Again
Back in 2018, when Jeff Brown told everyone to buy Tesla…
The "experts" said Elon was finished and Tesla was headed for bankruptcy.
Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. |
12/16/2024
3:39 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Quisel John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
7:48 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:03 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:46 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Savage William Jacob (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
11:15 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form EFFECT | |
11/19/2024
5:46 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:31 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:44 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
3:33 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G/A | |
MarketBeat All Access